Alaunos Therapeutics (TCRT) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to -$1.2 million.
- Alaunos Therapeutics' Profit After Tax fell 283.94% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 6583.48%. This contributed to the annual value of -$4.7 million for FY2024, which is 8668.47% up from last year.
- According to the latest figures from Q3 2025, Alaunos Therapeutics' Profit After Tax is -$1.2 million, which was down 283.94% from -$1.1 million recorded in Q2 2025.
- In the past 5 years, Alaunos Therapeutics' Profit After Tax registered a high of -$742000.0 during Q4 2024, and its lowest value of -$22.7 million during Q3 2021.
- Over the past 5 years, Alaunos Therapeutics' median Profit After Tax value was -$8.6 million (recorded in 2023), while the average stood at -$7.7 million.
- Per our database at Business Quant, Alaunos Therapeutics' Profit After Tax plummeted by 2190.79% in 2021 and then surged by 9053.93% in 2024.
- Alaunos Therapeutics' Profit After Tax (Quarter) stood at -$11.8 million in 2021, then increased by 22.34% to -$9.2 million in 2022, then grew by 14.37% to -$7.8 million in 2023, then skyrocketed by 90.54% to -$742000.0 in 2024, then tumbled by 56.2% to -$1.2 million in 2025.
- Its Profit After Tax stands at -$1.2 million for Q3 2025, versus -$1.1 million for Q2 2025 and -$1.1 million for Q1 2025.